# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-23-019581
Filing Date
2023-02-13
Accepted
2023-02-13 14:59:15
Documents
41
Period of Report
2023-02-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm236582d1_8k.htm iXBRL | 8-K | 28406
2 | EXHIBIT 99.1 | tm236582d1_ex99-1.htm | EX-99.1 | 37558
6 | GRAPHIC | tm236582d1_ex99-1img001.jpg | GRAPHIC | 110330
7 | GRAPHIC | tm236582d1_ex99-1img002.jpg | GRAPHIC | 216456
8 | GRAPHIC | tm236582d1_ex99-1img003.jpg | GRAPHIC | 204008
9 | GRAPHIC | tm236582d1_ex99-1img004.jpg | GRAPHIC | 160315
10 | GRAPHIC | tm236582d1_ex99-1img005.jpg | GRAPHIC | 101209
11 | GRAPHIC | tm236582d1_ex99-1img006.jpg | GRAPHIC | 147504
12 | GRAPHIC | tm236582d1_ex99-1img007.jpg | GRAPHIC | 179827
13 | GRAPHIC | tm236582d1_ex99-1img008.jpg | GRAPHIC | 175401
14 | GRAPHIC | tm236582d1_ex99-1img009.jpg | GRAPHIC | 141642
15 | GRAPHIC | tm236582d1_ex99-1img010.jpg | GRAPHIC | 137215
16 | GRAPHIC | tm236582d1_ex99-1img011.jpg | GRAPHIC | 141535
17 | GRAPHIC | tm236582d1_ex99-1img012.jpg | GRAPHIC | 132713
18 | GRAPHIC | tm236582d1_ex99-1img013.jpg | GRAPHIC | 132268
19 | GRAPHIC | tm236582d1_ex99-1img014.jpg | GRAPHIC | 126434
20 | GRAPHIC | tm236582d1_ex99-1img015.jpg | GRAPHIC | 115244
21 | GRAPHIC | tm236582d1_ex99-1img016.jpg | GRAPHIC | 118242
22 | GRAPHIC | tm236582d1_ex99-1img017.jpg | GRAPHIC | 143020
23 | GRAPHIC | tm236582d1_ex99-1img018.jpg | GRAPHIC | 140358
24 | GRAPHIC | tm236582d1_ex99-1img019.jpg | GRAPHIC | 241807
25 | GRAPHIC | tm236582d1_ex99-1img020.jpg | GRAPHIC | 177855
26 | GRAPHIC | tm236582d1_ex99-1img021.jpg | GRAPHIC | 176391
27 | GRAPHIC | tm236582d1_ex99-1img022.jpg | GRAPHIC | 153146
28 | GRAPHIC | tm236582d1_ex99-1img023.jpg | GRAPHIC | 73653
29 | GRAPHIC | tm236582d1_ex99-1img024.jpg | GRAPHIC | 124164
30 | GRAPHIC | tm236582d1_ex99-1img025.jpg | GRAPHIC | 150755
31 | GRAPHIC | tm236582d1_ex99-1img026.jpg | GRAPHIC | 137215
32 | GRAPHIC | tm236582d1_ex99-1img027.jpg | GRAPHIC | 153162
33 | GRAPHIC | tm236582d1_ex99-1img028.jpg | GRAPHIC | 92293
| Complete submission text file | 0001104659-23-019581.txt |  | 5908179

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | anvs-20230213.xsd | EX-101.SCH | 3039
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | anvs-20230213_lab.xml | EX-101.LAB | 34476
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | anvs-20230213_pre.xml | EX-101.PRE | 22599
35 | EXTRACTED XBRL INSTANCE DOCUMENT | tm236582d1_8k_htm.xml | XML | 3707

Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39202 | Film No.: 23617453
SIC: 2834 Pharmaceutical Preparations